Profile
Entourage Effect Capital is a cannabis investment firm headquartered in the United States. Initially founded as Cresco Capital Partners in 2014, the firm was rebranded to leverage the 'entourage effect'. The team is led by co-founders Matthew Hawkins, Dov Szapiro, and Andy Sturner, who have extensive backgrounds in private equity, turnaround management, and real estate. The firm boasts a deep bench of professionals with expertise in cannabis and various other industries, allowing them to differentiate themselves through unique insights and a strong network.
The firm primarily invests in growth-stage cannabis companies but also has an allocation for early-stage investments through its Arcview Ventures Seed Fund. Their current investment vehicle, Fund III, is focused on companies poised to scale in anticipation of federal legalization. With over $140 million deployed and more than 60 portfolio companies, Entourage Effect Capital is deeply embedded in the cannabis sector. The firm builds on its experience and partnerships to enhance value creation and identify emerging trends in North America.
Notable investments of Entourage Effect Capital include companies like Cann - cannabis beverages, TerrAscend - vertically integrated cannabis operator, Sunderstorm - cannabis edibles, Green Thumb Industries - multi-state operator, and Ebbu - cannabinoid research and development, along with others in their robust portfolio.
Industry
Entourage Effect Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Cannabis Fund III
|
Consumer Products
Cannabis
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$10-50 m
|
—
|
August 2026
|